ScholarIQanswers from OpenAlex & ORCID
Wei Wang
ResearcherPublications, citations & collaboration network
Wei Wang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Wei Wang have?
ScholarIQindexed works
Wei Wang has 778 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Wei Wang have?
ScholarIQcitation count
Wei Wang has 22,132 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Wei Wang?
ScholarIQh-index
Wei Wang has an h-index of 57 in OpenAlex.
What is the i10-index of Wei Wang?
ScholarIQi10-index
Wei Wang has an i10-index of 261 in OpenAlex.
What is the ORCID of Wei Wang?
ScholarIQorcid
The ORCID for Wei Wang is on the source record.
What is the OpenAlex record for Wei Wang?
ScholarIQopenalex
The OpenAlex for Wei Wang is on the source record.
What are the most-cited papers on Wei Wang?
ScholarIQmost cited works
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang, Wei‐jie Guan, Ruchong Chen, Wei Wang, Jianfu Li, Ke Xu, Caichen Li, Qing Ai, Weixiang Lu, Hengrui Liang, Shiyue Li, Jianxing He
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Wei-Jie Guan, Wenhua Liang, Yi Zhao, Heng-rui Liang, Zi‐Sheng Chen, Yimin Li, Xiao-qing Liu, Ru-chong Chen, Chun-li Tang, Tao Wang, Chun‐Quan Ou, Li Li, Ping-Yan Chen, Ling Sang, Wei Wang, Jian-fu Li, Caichen Li, Li-min Ou, Bo Cheng, Shan Xiong, Zheng-yi Ni, Jie Xiang, Yu Hu, Lei Liu, Hong Shan, Chun-liang Lei, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, Peng Peng, Jian Ming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, Chang-jiang Ye, Shao-yong Zhu, Lin-ling Cheng, Feng Ye, Shi-yue Li, Jin-ping Zheng, Nuo-fu Zhang, Nanshan Zhong, Jian-xing He
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Chuan Qin, Luo‐Qi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Tao Yu, Cuihong Xie, Ke Ma, Ke Shang, Wei Wang, Dai‐Shi Tian
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis
Wei‐jie Guan, Wenhua Liang, Yi Zhao, Hengrui Liang, Zisheng Chen, Yimin Li, Xiaoqing Liu, Ruchong Chen, Chunli Tang, Tao Wang, Chun‐Quan Ou, Li Li, Pingyan Chen, Ling Sang, Wei Wang, Jianfu Li, Caichen Li, Limin Ou, Bo Cheng, Shan Xiong, Zhengyi Ni, Jie Xiang, Yu Hu, Lei Liu, Hong Shan, Chunliang Lei, Yixiang Peng, Li Wei, Yong Liu, Yahua Hu, Peng Peng, Jianming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhijian Zheng, Shaoqin Qiu, Jie Luo, Chang-jiang Ye, Shaoyong Zhu, Linling Cheng, Feng Ye, Shiyue Li, Jin-ping Zheng, Nuofu Zhang, Nanshan Zhong, Jianxing He
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Yang Cao, Jia Wei, Liang Zou, Tiebin Jiang, Gaoxiang Wang, Liting Chen, Liang Huang, Fankai Meng, Lifang Huang, Na Wang, Xiaoxi Zhou, Hui Luo, Zekai Mao, Xing Chen, Jungang Xie, Jing Liu, Hui Cheng, Jianping Zhao, Gang Huang, Wei Wang, Jianfeng Zhou